硝酸甘油及其他氮氧化物在心血管治疗中的作用
本文综述了硝酸甘油自1847年合成以来在心血管治疗中的应用演变,重点阐述了一氧化氮作为生物效应分子在血管舒张、细胞通透性、血小板功能及炎症等过程中的作用,并介绍了有机硝酸盐的血流动力学与非血流动力学效应、多种给药途径、临床适应证(主要限于心绞痛,也用于部分心衰和肺高血压患者)以及硝酸盐耐受性的预防策略。
要点
- 有机硝酸盐临床主要用于心绞痛治疗,也用于部分心衰和肺高血压患者。
- 硝酸盐耐受性是主要限制,广泛接受的预防方法为每24小时提供无或低硝酸盐暴露间期。
- 硝酸甘油可经口腔黏膜、胃肠道和皮肤快速吸收,有多种给药途径。
核心结论
- 有机硝酸盐通过一氧化氮依赖和非依赖机制产生血流动力学(主要为血管舒张)和非血流动力学效应,临床数据主要支持其用于心绞痛治疗。
研究设计与样本
- 本文为综述,检索范围未在摘要中明确报告。
主要发现
- 硝酸甘油自1847年合成后不久即用于心绞痛治疗。
- 一氧化氮作为生物效应分子在血管舒张、细胞通透性、血小板功能、炎症等血管过程中发挥作用。
- 有机硝酸盐的血流动力学效应主要通过扩张容量血管和传导动脉介导。
- 硝酸盐可经口腔黏膜、胃肠道和皮肤快速吸收,硝酸甘油有多种给药途径。
- 有机硝酸盐也用于部分心衰和肺高血压患者。
关键数值与推荐
- 预防硝酸盐耐受性广泛接受的方法为每24小时提供无或低硝酸盐暴露间期。
- 其他预防耐受性的药物因缺乏支持性临床数据,目前均不推荐。
临床怎么用
- 临床主要将有机硝酸盐用于心绞痛治疗,部分心衰和肺高血压患者也可使用。
- 采用每24小时提供无或低硝酸盐暴露间期的给药策略预防耐受性。
局限性
- 临床数据限制有机硝酸盐的使用主要限于心绞痛治疗。
- 硝酸盐耐受性是主要限制。
- 其他预防耐受性的药物缺乏支持性临床数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The use of nitroglycerin in the treatment of angina pectoris began not long after its original synthesis in 1847. Since then, the discovery of nitric oxide as a biological effector and better understanding of its roles in vasodilation, cell permeability, platelet function, inflammation, and other vascular processes have advanced our knowledge of the hemodynamic (mostly mediated through vasodilation of capacitance and conductance arteries) and nonhemodynamic effects of organic nitrate therapy, via both nitric oxide-dependent and -independent mechanisms. Nitrates are rapidly absorbed from mucous membranes, the gastrointestinal tract, and the skin; thus, nitroglycerin is available in a number of preparations for delivery via several routes: oral tablets, sublingual tablets, buccal tablets, sublingual spray, transdermal ointment, and transdermal patch, as well as intravenous formulations. Organic nitrates are commonly used in the treatment of cardiovascular disease, but clinical data limit their use mostly to the treatment of angina. They are also used in the treatment of subsets of patients with heart failure and pulmonary hypertension. One major limitation of the use of nitrates is the development of tolerance. Although several agents have been studied for use in the prevention of nitrate tolerance, none are currently recommended owing to a paucity of supportive clinical data. Only 1 method of preventing nitrate tolerance remains widely accepted: the use of a dosing strategy that provides an interval of no or low nitrate exposure during each 24-h period. Nitric oxide's important role in several cardiovascular disease mechanisms continues to drive research toward finding novel ways to affect both endogenous and exogenous sources of this key molecular mediator.
引用
- Divakaran S, Loscalzo J. The Role of Nitroglycerin and Other Nitrogen Oxides in Cardiovascular Therapeutics. J Am Coll Cardiol. 2017. PMID: 29096811. doi:10.1016/j.jacc.2017.09.1064
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。